We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Brachytherapy a Fast Treatment for Breast Cancer

By HospiMedica staff writers
Posted on 31 May 2001
A study has demonstrated that brachytherapy for women with early-stage breast cancer can reduce treatment time to as little as five days, which is at least as effective as five weeks of standard radiation treatments. More...
Conducted by researchers at Beaumont Hospital (Royal Oak, MI, USA), the study was reported in the April 2001 issue of the Journal of Clinical Oncology.

The researchers compared the records of 174 women treated for early-stage breast cancer with brachytherapy for five days with those of women treated with external-beam radiation therapy for five weeks, over the period 1993 through January 2000. The results at a five-year follow-up were almost the same for both groups: 93% survival for brachytherapy patients and 90% for standard radiation patients, with no cancer found in 91% of the first group and 87% of the second group. These results make it possible for women to choose lumpectomy over breast removal for early-stage disease, especially women who have to travel long distances for radiation treatment and women with work or family commitments.

Dr. Frank Vicini, who led the study, noted that the brachytherapy involves placement of a catheter in the breast during lumpectomy but results in less skin reddening and perhaps less fatigue than standard radiation. He believes a longer study would be needed to determine whether brachytherapy might be better than standard radiation.




Related Links:
Beaumont Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.